Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer profit nosedives, Lipitor hurt by generic competition
Lipitor’s global revenue fell by 13% to $2.7 billion due to lower US demand and changes in wholesaler inventories, according to Pfizer. Compared with 2006, the company expects
Lipitor’s global revenue fell by 13% to $2.7 billion due to lower US demand and changes in wholesaler inventories, according to Pfizer. Compared with 2006, the company expects
US researchers compared 10 diabetes pills and found they all worked well to reduce blood sugar levels. The Glucophage drug, which costs about $100 a year, came out
The European Medicines Agency (EMEA) is reviewing Acomplia a month after US regulators rejected the drug on the grounds that the drug’s benefits failed to outweigh side-affects, including
ACAM-FLU-A is designed to target all ‘A’ strains of the influenza virus. As such, it has the potential to be both a universal pandemic influenza vaccine and part
Rotateq is a rotavirus vaccine, while Gardasil is for the prevention of cervical cancer. Both are being adopted in all 55 US immunization projects. “This milestone is an
This clinical trial of Trimesta (oral estriol) has received a $5 million grant from the National Multiple Sclerosis Society (NMSS) in partnership with the National MS Society’s Southern
The trial, named Upfront and conducted primarily at community physician networks nationwide, will compare three Velcade-based therapies. The company is developing the drug for registration in front-line MM
The collaboration, announced in December 2006, calls for Neuroptix to provide Merck with access to its laser eye scanning technologies, which in preclinical studies has detected Alzheimer’s-related amyloid
In conjunction with the US launch, the companies are also kicking off PD-Aware, a public education campaign which aims to raise the profile of Parkinson’s disease and highlight
BCX-4208 is an orally available small molecule inhibitor of purine nucleoside phosphorylase (PNP), an enzyme that is essential for the proliferation of activated T cells. With its novel